Novel Androgen Deprivation Treatment for Advanced Prostate Cancer

Annenberg Center for Health Sciences
  • 0.0 (0)
  • MEDICINE

Prostate cancer is the most common cancer diagnosed among men in the United States. Considered curable if diagnosed at a localized stage, the survival rate of men with metastatic disease is dramatically reduced. Due to the androgen-dependence of prostate cancer, androgen deprivation therapy (ADT) has been the mainstay and primary therapeutic approach for management of men with metastatic prostate cancer. Join Drs. Robert Dreicer and Michael Cookson as they review the principles of androgen deprivation therapy and discuss the latest clinical data for recently approved ADT agents and studies of

Episodes

  1. 12/10/2021

    Patient Preferences

    Patient Preferences

    8 min

  2. 12/10/2021

    Exploring Optimal Therapeutic Options

    Exploring Optimal Therapeutic Options

    19 min

  3. 12/10/2021

    Current State of Care in Advanced PCa

    Current State of Care in Advanced PCa

    40 min

  4. 12/10/2021

    Androgen Deprivation Therapy: Clinical Differences

    Androgen Deprivation Therapy: Clinical Differences

    10 min
  • 4 Episodes

About

Prostate cancer is the most common cancer diagnosed among men in the United States. Considered curable if diagnosed at a localized stage, the survival rate of men with metastatic disease is dramatically reduced. Due to the androgen-dependence of prostate cancer, androgen deprivation therapy (ADT) has been the mainstay and primary therapeutic approach for management of men with metastatic prostate cancer. Join Drs. Robert Dreicer and Michael Cookson as they review the principles of androgen deprivation therapy and discuss the latest clinical data for recently approved ADT agents and studies of

Information